Wyeth

Jennifer Stover

William L Trepicchio

Andrew J Dorner

Natalie C Twine

Michael E Burczynski

Donna K Slonim

Virginia Fitzpatrick

Joseph Boni

Fred Immermann

Methods, systems and equipment useful for monitoring in vivo activities of CCI-779 or other drugs. Numerous drug activity genes can be identified by the present invention. The expression profiles of these genes in peripheral blood mononuclear cells are modulatable by CCI-779 or other drugs. Therefore, these genes can be used as surrogate markers for detecting or monitoring drug activities in vivo.

Methods for monitoring drug activities in vivo

Methods, systems and equipment for diagnosing renal cell carcinoma (RCC) and other solid tumors. This invention identifies numerous disease genes that are differentially expressed in the peripheral blood of patients having RCC or other solid tumors relative to disease-free humans. These disease genes can be used as surrogate markers for detecting the presence or absence of RCC or other solid tumors.

Methods for diagnosing RCC and other solid tumors

Growing community of inventors

Topsfield, MA, United States of America

Jennifer Stover